Health
Canada approves Wegovy™ for the treatment of adults with
obesity | 2021.11.25 |
Health Canada
approves Norditropin NordiFlex® - first approved human growth
hormone treatment for Noonan syndrome in Canada
| 2021.06.25 |
Continued Support for Banting and Best’s
Insulin Discovery and Research at the University of
Toronto | 2021.04.12 |
Health Canada approves Saxenda® (liraglutide
injection) for the treatment of obesity in adolescents aged
12- <18 | 2021.03.03 |
Novo Nordisk and the University of Toronto
announce joint 200 DKK million investment to address diabetes
and chronic disease prevention | 2021.02.24 |
Camp Huronda receives $1.5M donation to
rebuild on-site medical centre |
2021.01.14 |